Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19.
Boras B, Jones RM, Anson BJ, Arenson D, Aschenbrenner L, Bakowski MA, Beutler N, Binder J, Chen E, Eng H, Hammond H, Hammond J, Haupt RE, Hoffman R, Kadar EP, Kania R, Kimoto E, Kirkpatrick MG, Lanyon L, Lendy EK, Lillis JR, Logue J, Luthra SA, Ma C, Mason SW, McGrath ME, Noell S, Obach RS, O' Brien MN, O'Connor R, Ogilvie K, Owen D, Pettersson M, Reese MR, Rogers TF, Rosales R, Rossulek MI, Sathish JG, Shirai N, Steppan C, Ticehurst M, Updyke LW, Weston S, Zhu Y, White KM, García-Sastre A, Wang J, Chatterjee AK, Mesecar AD, Frieman MB, Anderson AS, Allerton C. Boras B, et al. Nat Commun. 2021 Oct 18;12(1):6055. doi: 10.1038/s41467-021-26239-2. Nat Commun. 2021. PMID: 34663813 Free PMC article.
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19.
Boras B, Jones RM, Anson BJ, Arenson D, Aschenbrenner L, Bakowski MA, Beutler N, Binder J, Chen E, Eng H, Hammond H, Hammond J, Haupt RE, Hoffman R, Kadar EP, Kania R, Kimoto E, Kirkpatrick MG, Lanyon L, Lendy EK, Lillis JR, Logue J, Luthra SA, Ma C, Mason SW, McGrath ME, Noell S, Obach RS, O'Brien MN, O'Connor R, Ogilvie K, Owen D, Pettersson M, Reese MR, Rogers TF, Rossulek MI, Sathish JG, Shirai N, Steppan C, Ticehurst M, Updyke LW, Weston S, Zhu Y, Wang J, Chatterjee AK, Mesecar AD, Frieman MB, Anderson AS, Allerton C. Boras B, et al. bioRxiv [Preprint]. 2021 Feb 12:2020.09.12.293498. doi: 10.1101/2020.09.12.293498. bioRxiv. 2021. PMID: 32935104 Free PMC article. Updated. Preprint.
A comparative analysis of SARS-CoV-2 antivirals characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19.
de Vries M, Mohamed AS, Prescott RA, Valero-Jimenez AM, Desvignes L, O'Connor R, Steppan C, Devlin JC, Ivanova E, Herrera A, Schinlever A, Loose P, Ruggles K, Koralov SB, Anderson AS, Binder J, Dittmann M. de Vries M, et al. J Virol. 2021 Mar 10;95(7):e01819-20. doi: 10.1128/JVI.01819-20. Epub 2021 Feb 23. J Virol. 2021. PMID: 33622961 Free PMC article.
A comparative analysis of SARS-CoV-2 antivirals in human airway models characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19.
de Vries M, Mohamed AS, Prescott RA, Valero-Jimenez AM, Desvignes L, O'Connor R, Steppan C, Devlin JC, Ivanova E, Herrera A, Schinlever A, Loose P, Ruggles K, Koralov SB, Anderson AS, Binder J, Dittmann M. de Vries M, et al. bioRxiv [Preprint]. 2021 Feb 19:2020.08.28.272880. doi: 10.1101/2020.08.28.272880. bioRxiv. 2021. PMID: 32869028 Free PMC article. Updated. Preprint.
Post-ICU psychology support during the COVID-19 pandemic.
Reynolds-Cowie P, Kirkwood K, O'Connor R. Reynolds-Cowie P, et al. Among authors: o connor r. Nurs Crit Care. 2024 May 11. doi: 10.1111/nicc.13087. Online ahead of print. Nurs Crit Care. 2024. PMID: 38733236
Social intuition: behavioral and neurobiological considerations.
Jellema T, Macinska ST, O'Connor RJ, Skodova T. Jellema T, et al. Among authors: o connor rj. Front Psychol. 2024 Apr 23;15:1336363. doi: 10.3389/fpsyg.2024.1336363. eCollection 2024. Front Psychol. 2024. PMID: 38716269 Free PMC article.
Psychometric Validation of the Gambling Craving Scale in a Treatment-Seeking Sample.
Battaglia AM, Vedelago L, Coelho SG, Baumgartner C, Schaub MP, Stewart SH, MacKillop J, Hodgins DC, Wardell JD, O'Connor RM, Kim HS, Keough MT. Battaglia AM, et al. Among authors: o connor rm. J Gambl Stud. 2024 May 3. doi: 10.1007/s10899-024-10306-6. Online ahead of print. J Gambl Stud. 2024. PMID: 38700740
4-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter study.
Estroff JM, Devlin J, Hoteit L, Hassoune A, Neal MD, Brown JB, Lu L, Kotch S, Hazelton JP, Christian AB, Yeates EO, Nahmias J, Jacobson LE, Williams J, Schuster KM, O'Connor R, Semon GR, Straughn AD, Cullinane D, Egodage T, Kincaid M, Rollins A, Amdur R, Sarani B. Estroff JM, et al. Among authors: o connor r. J Trauma Acute Care Surg. 2024 Apr 30. doi: 10.1097/TA.0000000000004345. Online ahead of print. J Trauma Acute Care Surg. 2024. PMID: 38685190
Amygdala-liver signaling orchestrates rapid glycemic responses to stress and drives stress-induced metabolic dysfunction.
Stanley S, Devarakonda K, O'Connor R, Jimenez-Gonzalez M, Alvarsson A, Hampton R, Espinoza D, Li R, Shtekler A, Conner K, Bayne M, Garibay D, Martin J, Lehmann V, Wang L, Kenny P. Stanley S, et al. Among authors: o connor r. Res Sq [Preprint]. 2024 Mar 29:rs.3.rs-2924278. doi: 10.21203/rs.3.rs-2924278/v1. Res Sq. 2024. PMID: 38585822 Free PMC article. Preprint.
2,209 results